🔗 Visit the ClinicalTrials.gov page for NCT01509339
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. | Am J Respir Crit Care Med | 2008 | 2.63 |
| 2 | Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. | JAMA | 2010 | 1.69 |
| 3 | Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis. | Curr Opin Pulm Med | 2011 | 0.88 |
| 4 | Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres. | J Cyst Fibros | 2010 | 0.87 |
| 5 | The Murine Lung Microbiome Changes During Lung Inflammation and Intranasal Vancomycin Treatment. | Open Microbiol J | 2015 | 0.81 |